Pancreatic Cancer Research

ResearcherNational Yang Ming Chiao Tung UniversityActive in the last 2 years

Hung-Yuan Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7170-3502; OpenAlex author ID A5048216576. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. Co-author DOI 10.1016/j.radonc.2025.111238↗
  2. Comprehensive review of current management and precision medicine in pancreatic cancer. Co-author DOI 10.1097/jcma.0000000000001365↗
  3. NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-… Co-author DOI 10.1177/17588359261431386↗
  4. Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis. Co-author DOI 10.1186/s12885-025-13896-5↗
  5. Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: A real-world experience. Co-author DOI 10.1097/jcma.0000000000000650↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chung‐Pin Li · 5 shared papers, 2022–2026 · strength 1.44
  2. Yee Chao · 3 shared papers, 2022–2026 · strength 0.94
  3. Nai‐Jung Chiang · 2 shared papers, 2026 · strength 0.50
  4. Fa‐Yauh Lee · 1 shared paper, 2026 · strength 0.27
  5. Kuei‐Chuan Lee · 1 shared paper, 2026 · strength 0.27
  6. W. J. Wong · 1 shared paper, 2026 · strength 0.27
  7. Keng-Li Lan · 1 shared paper, 2026 · strength 0.23
  8. I‐Chun Lai · 1 shared paper, 2026 · strength 0.23
  9. Yu‐Wen Hu · 1 shared paper, 2026 · strength 0.23
  10. Yuan‐Hung Wu · 1 shared paper, 2026 · strength 0.23
  11. Minghuang Chen · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.